BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36632749)

  • 1. Hypoxia-induced ROS aggravate tumor progression through HIF-1α-SERPINE1 signaling in glioblastoma.
    Zhang L; Cao Y; Guo X; Wang X; Han X; Kanwore K; Hong X; Zhou H; Gao D
    J Zhejiang Univ Sci B; 2023 Jan; 24(1):32-49. PubMed ID: 36632749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia Accelerates Aggressiveness of Hepatocellular Carcinoma Cells Involving Oxidative Stress, Epithelial-Mesenchymal Transition and Non-Canonical Hedgehog Signaling.
    Liu Z; Tu K; Wang Y; Yao B; Li Q; Wang L; Dou C; Liu Q; Zheng X
    Cell Physiol Biochem; 2017; 44(5):1856-1868. PubMed ID: 29237157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH oxidase subunit 4-mediated reactive oxygen species contribute to cycling hypoxia-promoted tumor progression in glioblastoma multiforme.
    Hsieh CH; Shyu WC; Chiang CY; Kuo JW; Shen WC; Liu RS
    PLoS One; 2011; 6(9):e23945. PubMed ID: 21935366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.
    Jin P; Shin SH; Chun YS; Shin HW; Shin YJ; Lee Y; Kim D; Nam DH; Park JW
    Oncogene; 2018 Jun; 37(23):3070-3087. PubMed ID: 29535421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cycling hypoxia induces chemoresistance through the activation of reactive oxygen species-mediated B-cell lymphoma extra-long pathway in glioblastoma multiforme.
    Chen WL; Wang CC; Lin YJ; Wu CP; Hsieh CH
    J Transl Med; 2015 Dec; 13():389. PubMed ID: 26711814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity.
    Hsieh CH; Lee CH; Liang JA; Yu CY; Shyu WC
    Oncol Rep; 2010 Dec; 24(6):1629-36. PubMed ID: 21042761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOX4-Derived ROS Mediates TGF-
    Su X; Yang Y; Guo C; Zhang R; Sun S; Wang Y; Qiao Q; Fu Y; Pang Q
    Oxid Med Cell Longev; 2021; 2021():5549047. PubMed ID: 34257808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K/Akt/mTOR/HIF-1α pathway.
    Huang W; Ding X; Ye H; Wang J; Shao J; Huang T
    Neuroreport; 2018 Dec; 29(18):1578-1585. PubMed ID: 30371540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1α.
    Zhang Y; Liu Q; Wang F; Ling EA; Liu S; Wang L; Yang Y; Yao L; Chen X; Wang F; Shi W; Gao M; Hao A
    J Pineal Res; 2013 Sep; 55(2):121-30. PubMed ID: 23551342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geranylgeranyltransferase I regulates HIF-1α promoting glioblastoma cell migration and invasion.
    Zhou X; Liu Z; Shi Q; Jiao J; Bian W; Song X; Mo J; Sang B; Xu Y; Qian J; Chao Y; Yu R
    J Neurooncol; 2013 May; 112(3):365-74. PubMed ID: 23475391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferoxamine promotes MDA-MB-231 cell migration and invasion through increased ROS-dependent HIF-1α accumulation.
    Liu Y; Cui Y; Shi M; Zhang Q; Wang Q; Chen X
    Cell Physiol Biochem; 2014; 33(4):1036-46. PubMed ID: 24732598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment.
    Nigim F; Cavanaugh J; Patel AP; Curry WT; Esaki S; Kasper EM; Chi AS; Louis DN; Martuza RL; Rabkin SD; Wakimoto H
    J Neuropathol Exp Neurol; 2015 Jul; 74(7):710-22. PubMed ID: 26083570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
    Li W; Cao L; Chen X; Lei J; Ma Q
    Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1.
    Chou CW; Wang CC; Wu CP; Lin YJ; Lee YC; Cheng YW; Hsieh CH
    Neuro Oncol; 2012 Oct; 14(10):1227-38. PubMed ID: 22946104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDH1-R132H Suppresses Glioblastoma Malignancy through FAT1-ROS-HIF-1α Signaling.
    Li LC; Zhang M; Feng YK; Wang XJ
    Neurol India; 2020; 68(5):1050-1058. PubMed ID: 33109851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells.
    Bordji K; Grandval A; Cuhna-Alves L; Lechapt-Zalcman E; Bernaudin M
    FEBS J; 2014 Dec; 281(23):5220-36. PubMed ID: 25244496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.
    Hsieh CH; Wu CP; Lee HT; Liang JA; Yu CY; Lin YJ
    Free Radic Biol Med; 2012 Aug; 53(4):649-58. PubMed ID: 22713363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species produced by the knockdown of manganese-superoxide dismutase up-regulate hypoxia-inducible factor-1alpha expression in oral squamous cell carcinoma cells.
    Sasabe E; Yang Z; Ohno S; Yamamoto T
    Free Radic Biol Med; 2010 May; 48(10):1321-9. PubMed ID: 20188165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.